Genetic and family counselling for schizophrenia: Where do we stand now?

Background: Recent genetic findings have led to profound changes in genetic and family counselling for schizophrenia patients and their families. Objectives: The article gives an overview of the present knowledge regarding the genetic and family counselling for schizophrenia. Method: Literature se...

Full description

Bibliographic Details
Main Author: Johannes L. Roos
Format: Article
Language:English
Published: AOSIS 2016-05-01
Series:South African Journal of Psychiatry
Online Access:http://www.sajp.org.za/index.php/sajp/article/view/831
id doaj-9d2663a3726a4ca9bdfa0c6b0a566e7d
record_format Article
spelling doaj-9d2663a3726a4ca9bdfa0c6b0a566e7d2020-11-24T23:50:15ZengAOSISSouth African Journal of Psychiatry 1608-96852078-67862016-05-01221e1e610.4102/sajpsychiatry.v22i1.831332Genetic and family counselling for schizophrenia: Where do we stand now?Johannes L. Roos0Department of Psychiatry, University of PretoriaBackground: Recent genetic findings have led to profound changes in genetic and family counselling for schizophrenia patients and their families. Objectives: The article gives an overview of the present knowledge regarding the genetic and family counselling for schizophrenia. Method: Literature searches were performed on the MEDLINE database (2011–2015) and African Healthline. A current alert service which provides the most recent literature on the topic on a monthly basis was also used in the study. A clinical case example is presented as is experienced in daily psychiatric practice. Results: Genetic risk communication has become the responsibility of the multiprofessional treatment team, moving away from specialists in the field. The treatment team provides information on a daily basis regarding risk predictors in the management of schizophrenia, including risk of relapse, suicide and comorbid substance use. Although genetic information is unique and has implications for blood relatives, genetic risk factors only rarely provide information that is inherently different from that provided by other risk predictors commonly used in healthcare. The common variant common disease and rare variant common disease models as contrasting hypothesis of the genetics of schizophrenia are discussed and debated. An example of a family counselled is given and the place of commercial companies that offer directly to the consumer affordable personal DNA testing for psychiatric illness is discussed. Ethical issues without resolution regarding genetic counselling of schizophrenia are debated. Conclusions: Recent genetic findings must lead to profound changes in genetic and family counselling in schizophrenia. Exposed attributable risk has immediate effects on genetic counselling of schizophrenia. Psychiatric risk counselling has thus changed from risk estimates based on family history to estimates based on test results in specific individuals.http://www.sajp.org.za/index.php/sajp/article/view/831
collection DOAJ
language English
format Article
sources DOAJ
author Johannes L. Roos
spellingShingle Johannes L. Roos
Genetic and family counselling for schizophrenia: Where do we stand now?
South African Journal of Psychiatry
author_facet Johannes L. Roos
author_sort Johannes L. Roos
title Genetic and family counselling for schizophrenia: Where do we stand now?
title_short Genetic and family counselling for schizophrenia: Where do we stand now?
title_full Genetic and family counselling for schizophrenia: Where do we stand now?
title_fullStr Genetic and family counselling for schizophrenia: Where do we stand now?
title_full_unstemmed Genetic and family counselling for schizophrenia: Where do we stand now?
title_sort genetic and family counselling for schizophrenia: where do we stand now?
publisher AOSIS
series South African Journal of Psychiatry
issn 1608-9685
2078-6786
publishDate 2016-05-01
description Background: Recent genetic findings have led to profound changes in genetic and family counselling for schizophrenia patients and their families. Objectives: The article gives an overview of the present knowledge regarding the genetic and family counselling for schizophrenia. Method: Literature searches were performed on the MEDLINE database (2011–2015) and African Healthline. A current alert service which provides the most recent literature on the topic on a monthly basis was also used in the study. A clinical case example is presented as is experienced in daily psychiatric practice. Results: Genetic risk communication has become the responsibility of the multiprofessional treatment team, moving away from specialists in the field. The treatment team provides information on a daily basis regarding risk predictors in the management of schizophrenia, including risk of relapse, suicide and comorbid substance use. Although genetic information is unique and has implications for blood relatives, genetic risk factors only rarely provide information that is inherently different from that provided by other risk predictors commonly used in healthcare. The common variant common disease and rare variant common disease models as contrasting hypothesis of the genetics of schizophrenia are discussed and debated. An example of a family counselled is given and the place of commercial companies that offer directly to the consumer affordable personal DNA testing for psychiatric illness is discussed. Ethical issues without resolution regarding genetic counselling of schizophrenia are debated. Conclusions: Recent genetic findings must lead to profound changes in genetic and family counselling in schizophrenia. Exposed attributable risk has immediate effects on genetic counselling of schizophrenia. Psychiatric risk counselling has thus changed from risk estimates based on family history to estimates based on test results in specific individuals.
url http://www.sajp.org.za/index.php/sajp/article/view/831
work_keys_str_mv AT johanneslroos geneticandfamilycounsellingforschizophreniawheredowestandnow
_version_ 1725479470057390080